Dr Reddys Laboratories Share Price Today - Live Blog for October 09, 2025

Demonstrating a commendable 0.02% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,246.20. In terms of valuation, the stock maintains a PE ratio of 17.9400, while the industry PE ratio stands at 34.5644.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.07% drop, and it's now trading at ₹1,245.35 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

After a notable 0.02% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,245.75. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

The stock of Dr Reddys Laboratories Ltd suffered a -0.09% decline, and it currently trades at ₹1,245.55 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Dr Reddys Laboratories Ltd plunged by -0.03%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,246.00, but investors are assessing whether this is a temporary dip or a long-term trend.

The stock of Dr Reddys Laboratories Ltd suffered a -0.12% decline, and it currently trades at ₹1,246.40 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd shares experienced a -0.04% reduction, with the current market price at ₹1,247.95. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's share price has dropped by -0.03%, a development that warrants careful analysis. Presently trading at ₹1,248.05, investors are assessing whether this presents an opportunity or a risk.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.19% drop, and it's now trading at ₹1,249.50 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd stock price decreased by -0.02%, with the current market value at ₹1,251.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.46%, reaching the current market price of ₹1,251.75. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

After a -0.04% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,246.00. The stock has a PE ratio of 17.9400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has dropped by -0.69%, a development that warrants careful analysis. Presently trading at ₹1,249.90, investors are assessing whether this presents an opportunity or a risk.

After a -0.69% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,249.90. The stock has a PE ratio of 17.9400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd plunged by -0.69%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,249.90, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd experienced a -0.28% downturn in its share price, and it's currently trading at ₹1,259.35. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.01% increase. Presently, it is actively trading at ₹1,262.10.

Dr Reddys Laboratories Ltd experienced a substantial 0.12% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,260.65, making it an appealing option for investors.

Dr Reddys Laboratories Ltd shares experienced a -0.15% reduction, with the current market price at ₹1,256.90. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The stock of Dr Reddys Laboratories Ltd suffered a -0.15% drop, and it's now trading at ₹1,256.90 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd's stock price surged by 0.05%, reaching the current market value of ₹1,260.00 per share. This surge is a testament to the stock's recent performance.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.19%. At this moment, it's actively trading at ₹1,259.00, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd experienced a -0.16% dip in its share price and is currently trading at ₹1,255.00. The stock has a PE ratio of 17.9400, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

With a -0.11% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,255.80. The stock is currently trading at a PE of 17.9400, while the industry PE is 34.5644, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 1.68% uptick in its share price. As a result, it's now actively trading at ₹1,255.10 per share, making it an attractive option for investors.